Blanket Purchase Agreement 36F79719D0024-36C24225A0048

Award Date 8/1/25
Last Date to Order 7/31/26
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 to Abbott Laboratories Inc. provides medical diagnostic equipment, reagents, and related consumables to support clinical laboratory operations and patient care programs across the VA healthcare system. The BPA, with a total ceiling value of $6,814,936.50, is issued under Abbott's existing General Services Administration (GSA) Federal Supply Schedule contract for...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 to Abbott Laboratories Inc., a global healthcare company. The BPA has a ceiling value of $3,861,550.32 and a period of performance through June 29, 2027. It was issued under the GSA Federal Supply Schedule for Critical Analyzers and Laboratory Equipment (FSS-66-III), enabling the VA to efficiently procure a variety of SARS-CoV-2 and HIV diagnostic testing...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 (VISN 15) to Abbott Laboratories Inc., a global healthcare company. The contract, which is not set aside, has a total ceiling value of $37,591,829.45 and a period of performance through July 31, 2027. The BPA is intended to provide the VA with a range of medical diagnostic equipment, reagents, and clinical laboratory services, including automated chemistry and...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 10 to Abbott Laboratories Inc., a global healthcare company, for the provision of chemistry, immunochemistry, and immunoassay testing services, automated analyzers, reagents, test kits, and associated equipment and consumables. The $7.5 million BPA was established under Abbott's existing General Services Administration (GSA) Federal Supply Schedule contract for...
This Blanket Purchase Agreement (BPA) contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Abbott Laboratories Inc., a global healthcare company, to provide chemistry immunoassay testing services and supplies. The single-award BPA has a ceiling value of $4,300,000 and a period of performance through September 30, 2026. The contract is a call against Abbott's existing General Services Administration (GSA) Federal Supply Schedule for...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 (VISN 20) to Abbott Laboratories Inc., a global healthcare company, for the delivery of chemistry analyzers and associated laboratory equipment, reagents, and consumables. The contract has a total ceiling value of $13,199,994.50 and a performance period running through June 30, 2026. It was established under the General Services Administration (GSA) Federal...
The provided information details a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc. for medical diagnostic products and services. The contract, valued at $2,130,000.00, was awarded under the GSA Federal Supply Schedule 66-III for Critical Analyzers and Laboratory equipment. The BPA has a performance period from July 1, 2025 to June 30, 2026. Under this single-award BPA, Abbott Laboratories will provide the North Texas Veterans Health...
This Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 23 (VISN 23) to Abbott Laboratories Inc. provides automated chemistry and immunochemistry instrumentation, reagents, and related services to support clinical laboratory operations across VA healthcare facilities. The single-award, firm fixed-price contract, with a total ceiling value of $6,640,812.54, was established under the General Services Administration (GSA)...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company and manufacturer of medical devices, diagnostic equipment, pharmaceuticals, and clinical testing technologies. The contract, valued at a ceiling of $1,652,770.00, is for the delivery of i-STAT point-of-care handheld blood analyzers and associated reagents. The BPA, which does not have a set-aside designation, will be used by the VA's...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 (VISN 19) to Abbott Laboratories Inc., a global healthcare company. The BPA, valued at up to $1,750,000, provides the VA with a range of medical diagnostic equipment, reagents, and associated consumables for infectious disease testing, including capabilities for COVID-19 screening. The contract was awarded under the General Services Administration (GSA) Federal...

This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 2 (VISN 2), to Abbott Laboratories Inc. The single-award BPA has a total ceiling value of $1,225,948.60 and a period of performance from August 1, 2025, to July 31, 2026. The BPA will provide the James J. Peters VA Medical Center and New York Harbor Healthcare System with consumables and supplies for laboratory testing equipment, including two identical single-platform immunoassay analyzers. The analyzers will be used to perform a comprehensive menu of medical tests, such as HIV, Hepatitis, Tacrolimus, Cyclosporine, Sirolimus, and SARS-CoV-2 IgG testing. This sole-source procurement is being conducted under the Federal Supply Schedule (FSS) contract #36F79719D0024, without any set-aside designation. The current BPA with Abbott Laboratories is set to expire on July 31, 2025, prompting this new procurement action. The VA seeks to ensure uninterrupted diagnostic capabilities across its medical facilities in VISN 2 through this BPA.

The original solicitation was issued as a Special Notice, indicating the VA's intent to award this sole-source BPA to Abbott Laboratories. The procurement is classified under NAICS code 334516, Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees. The VA emphasizes that the selected analyzers must demonstrate at least a 95% confidence interval for sensitivity and specificity across the various medical tests. This sole-source award to Abbott Laboratories is facilitated through the company's existing FSS contract, eliminating the need for a formal solicitation process.

Generated 7/24/25, 9:46 AM